• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[韦尔纳-莫里森综合征中的血管活性肠肽]

[The vaso-active intestinal polypeptide in Verner-Morrison syndrome].

作者信息

Seif F J, Sadowski P, Heni F, Fischer R, Bloom S R, Polak J M

出版信息

Dtsch Med Wochenschr. 1975 Feb 28;100(9):399-405. doi: 10.1055/s-0028-1106226.

DOI:10.1055/s-0028-1106226
PMID:163727
Abstract

A 40-year-old man with the Verner-Morrison syndrome (refractory watery diarrhoea and hypokalaemia in islet-cell tumour of the pancreas) had an islet-cell carcinoma of the non-B-cell type with metastases to liver and mesenteric lymph nodes. High concentrations of a vasoactive intestinal polypeptide (VIP) were demonstrated in tumour tissue and plasma by radioimmunological tests. After surgical removal of the tumour the plasma VIP concentration fell to normal. Immunohistochemical tests of the tumour for gastrointestinal hormones demonstrated marked fluorescence only for vaso-active intestinal polypeptide. It is assumed that this polypeptide is largely responsible for the clinical signs. In the described case the severe watery diarrhoea ceased after glucocorticoid administration.

摘要

一名患有韦尔纳 - 莫里森综合征(胰腺胰岛细胞瘤导致难治性水样腹泻和低钾血症)的40岁男性,患有非B细胞型胰岛细胞癌,并伴有肝转移和肠系膜淋巴结转移。通过放射免疫试验在肿瘤组织和血浆中检测到高浓度的血管活性肠多肽(VIP)。手术切除肿瘤后,血浆VIP浓度降至正常。对肿瘤进行的胃肠道激素免疫组织化学检测显示,仅血管活性肠多肽有明显荧光。推测该多肽在很大程度上导致了临床症状。在所描述的病例中,糖皮质激素给药后严重水样腹泻停止。

相似文献

1
[The vaso-active intestinal polypeptide in Verner-Morrison syndrome].[韦尔纳-莫里森综合征中的血管活性肠肽]
Dtsch Med Wochenschr. 1975 Feb 28;100(9):399-405. doi: 10.1055/s-0028-1106226.
2
[VIP and GIP-producing pancreatic tumour: relationship to the Verner-Morrison syndrome].
Dtsch Med Wochenschr. 1976 Jun 11;101(24):920-3. doi: 10.1055/s-0028-1104188.
3
Verner-Morrison syndrome and vasoactive intestinal polypeptide (VIP).韦纳-莫里森综合征与血管活性肠肽(VIP)。
Scand J Gastroenterol Suppl. 1979;53:57-60.
4
Vasoactive intestinal polypeptide and gastrin-producing islet cell carcinoma.
Arch Pathol Lab Med. 1977 May;101(5):262-5.
5
[Vasoactive intestinal peptide (VIP) in the Verner-Morrison syndrome (author's transl)].韦纳-莫里森综合征中的血管活性肠肽(作者译)
Nouv Presse Med. 1979 Apr 21;8(18):1505-8.
6
Streptozocin-treated Verner-Morrison Syndrome: plasma vasoactive intestinal peptide and tumor responses.
Arch Intern Med. 1976 Dec;136(12):1429-35.
7
Streptozotocin treatment of a juvenile onset type diabetic patient with Verner-Morrison syndrome and multi hormonal probable malignant islet cell carcinoma with liver metastases.
Horm Metab Res. 1982 Jun;14(6):327-8. doi: 10.1055/s-2007-1019007.
8
Streptozotocin treatment of a pancreatic tumour producing VIP and gastrin associated with Verner-Morrison syndrome.用链脲佐菌素治疗一例产生血管活性肠肽和胃泌素并伴有韦尔纳-莫里森综合征的胰腺肿瘤。
Acta Med Scand. 1979;206(3):223-7. doi: 10.1111/j.0954-6820.1979.tb13499.x.
9
Proceedings: Vasoactive intestinal peptide and the Verner-Morrison syndrome.会议论文:血管活性肠肽与韦纳 - 莫里森综合征
Gut. 1975 May;16(5):399.
10
[Verner-Morrison syndrome].[韦纳-莫里森综合征]
Chirurg. 1975 May;46(5):225-8.

引用本文的文献

1
Effects of vasoactive intestinal polypeptide on intestinal absorption and blood flow.血管活性肠肽对肠道吸收及血流的影响。
J Physiol. 1978 Jun;279:121-32. doi: 10.1113/jphysiol.1978.sp012334.
2
Prostaglandins and serotonin: nonpeptide diarrheogenic hormones.前列腺素和血清素:非肽类致泻激素。
World J Surg. 1979 Sep 20;3(5):565-78. doi: 10.1007/BF01654761.
3
Prostaglandins E and F in endocrine diarrheagenic syndromes.内分泌性腹泻综合征中的前列腺素E和F
Ann Surg. 1976 Oct;184(4):516-24. doi: 10.1097/00000658-197610000-00015.
4
[Diarrhea and islet cell tumor. Clinical and morphological report on 2 observations].[腹泻与胰岛细胞瘤。两例临床及形态学报告]
Klin Wochenschr. 1976 Jan 1;54(1):13-7. doi: 10.1007/BF01466981.
5
[The Verner-Morrison syndrome. The clinical picture and pathologic anatomy].[韦尔纳-莫里森综合征。临床表现与病理解剖]
Klin Wochenschr. 1976 Jan 1;54(1):1-11. doi: 10.1007/BF01466980.